Education
About Us
Working with TipRanks
Follow Us
Conmed (CNMD)
NYSE:CNMD
CNMD Stock Chart & Stats
$44.35
$0.19(0.28%)
At close: 4:00 PM EST
$44.35
$0.19(0.28%)
Day’s Range― - ―
52-Week Range$38.32 - $74.75
Previous CloseN/A
Volume49.43K
Average Volume (3M)368.83K
Market Cap
$1.23B
Enterprise Value$2.47B
Total Cash (Recent Filing)$38.93M
Total Debt (Recent Filing)$853.75M
Price to Earnings (P/E)19.3
Beta0.47
Next Earnings
Jan 29, 2026EPS Estimate
1.32Next Dividend Ex-DateN/A
Dividend Yield2.01%
Share Statistics
EPS (TTM)1.08
Shares Outstanding30,967,955
10 Day Avg. Volume284,080
30 Day Avg. Volume368,831
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)2.19
Price to Sales (P/S)1.62
P/FCF Ratio13.72
Enterprise Value/Market Cap2.00
Enterprise Value/Revenue1.83
Enterprise Value/Gross Profit3.37
Enterprise Value/Ebitda12.87
Forecast
1Y Price Target
$53.50Price Target Upside20.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Gross Margin ImprovementCNMD expects this deal to be 80bps accretive to gross margin.
Portfolio OptimizationCNMD announced its intention to exit its gastroenterology product lines as part of its broader portfolio optimization strategy.
Revenue And EPS GrowthCNMD's 3Q25 revenue and EPS beat consensus.
Bears Say
Dividend SuspensionCNMD announced that it was suspending its dividend payments in favor of share repurchases.
Future EPS ImpactThe exit from the gastroenterology business is expected to reduce CNMD's adjusted earnings per share in 2026.
Margin DeclineGross margin and operating margin were both down 40 bps Y/Y.
Conmed News
CNMD FAQ
What was Conmed’s price range in the past 12 months?
Conmed lowest stock price was $38.32 and its highest was $74.75 in the past 12 months.
What is Conmed’s market cap?
Conmed’s market cap is $1.23B.
When is Conmed’s upcoming earnings report date?
Conmed’s upcoming earnings report date is Jan 29, 2026 which is in 40 days.
How were Conmed’s earnings last quarter?
Conmed released its earnings results on Nov 05, 2025. The company reported $1.08 earnings per share for the quarter, beating the consensus estimate of $1.062 by $0.018.
Is Conmed overvalued?
According to Wall Street analysts Conmed’s price is currently Undervalued.
Does Conmed pay dividends?
Conmed pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 2.01%. See more information on Conmed dividends here
What is Conmed’s EPS estimate?
Conmed’s EPS estimate is 1.32.
How many shares outstanding does Conmed have?
Conmed has 30,967,955 shares outstanding.
What happened to Conmed’s price movement after its last earnings report?
Conmed reported an EPS of $1.08 in its last earnings report, beating expectations of $1.062. Following the earnings report the stock price went down -0.518%.
Which hedge fund is a major shareholder of Conmed?
Currently, no hedge funds are holding shares in CNMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Conmed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$53.50 (20.63% Upside)
$53.50 (20.63% Upside)
Hedge Fund Trend
Increased
By 106.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $268.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.21%
12-Months-Change
Fundamentals
Return on Equity
6.60%
Trailing 12-Months
Asset Growth
1.87%
Trailing 12-Months
Company Description
Conmed
Conmed Corporation (CNMD) is a global medical technology company that specializes in the development and manufacturing of surgical devices and equipment. Operating primarily in the surgical and orthopedic sectors, Conmed offers a comprehensive range of products including electrosurgical instruments, surgical imaging systems, and orthopedic implants. The company's innovations are designed to enhance surgical outcomes and improve patient care, catering to a diverse clientele that includes hospitals, surgical centers, and healthcare professionals worldwide.
CNMD Company Deck
CNMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and strategic initiatives aimed at improving long-term profitability and shareholder value. However, challenges such as tariff impacts on margins and a significant decrease in GAAP net income were noted. The shift in capital allocation from dividends to share repurchases indicates a strategic focus on enhancing financial flexibility.View all CNMD earnings summariesCNMD Stock 12 Month Forecast
Average Price Target
$53.50
▲(20.63% Upside)
Technical Analysis
Artivion
―
Integra Lifesciences
―
Ufp Technologies
―
AdaptHealth
―
PROCEPT BioRobotics
―
Ownership Overview
Currently, No data available
---